Novel treatments for rare cancers: the U.S. orphan drug act is delivering : a cross-sectional analysis
The U.S. Orphan Drug Act of 1983 and associated incentives have fostered delivery of novel treatments for rare cancers. Quantitative cross-sectional analysis on the U.S. Food and Drug Administration Orphan Drug Product database found that more than one-third of all orphan drug approvals address need...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2016 Mar 28
|
| In: |
The oncologist
Year: 2016, Jahrgang: 21, Heft: 4, Pages: 487-493 |
| ISSN: | 1549-490X |
| DOI: | 10.1634/theoncologist.2015-0397 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1634/theoncologist.2015-0397 Verlag, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828121/ 
|
| Verfasserangaben: | Clemens Stockklausner, Anette Lampert, Georg F. Hoffmann, Markus Ries |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1664981462 | ||
| 003 | DE-627 | ||
| 005 | 20230426130909.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190508s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1634/theoncologist.2015-0397 |2 doi | |
| 035 | |a (DE-627)1664981462 | ||
| 035 | |a (DE-599)KXP1664981462 | ||
| 035 | |a (OCoLC)1341212600 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Stockklausner, Clemens |d 1976- |e VerfasserIn |0 (DE-588)123997747 |0 (DE-627)706503155 |0 (DE-576)185367720 |4 aut | |
| 245 | 1 | 0 | |a Novel treatments for rare cancers |b the U.S. orphan drug act is delivering : a cross-sectional analysis |c Clemens Stockklausner, Anette Lampert, Georg F. Hoffmann, Markus Ries |
| 264 | 1 | |c 2016 Mar 28 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 08.05.2019 | ||
| 520 | |a The U.S. Orphan Drug Act of 1983 and associated incentives have fostered delivery of novel treatments for rare cancers. Quantitative cross-sectional analysis on the U.S. Food and Drug Administration Orphan Drug Product database found that more than one-third of all orphan drug approvals address needs of patients suffering from rare cancers. | ||
| 700 | 1 | |a Lampert, Anette |d 1987- |e VerfasserIn |0 (DE-588)1094705209 |0 (DE-627)855112654 |0 (DE-576)462810666 |4 aut | |
| 700 | 1 | |a Hoffmann, Georg F. |d 1957- |e VerfasserIn |0 (DE-588)115652868 |0 (DE-627)077386116 |0 (DE-576)261230042 |4 aut | |
| 700 | 1 | |a Ries, Markus |d 1971- |e VerfasserIn |0 (DE-588)136385338 |0 (DE-627)582068479 |0 (DE-576)300993358 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The oncologist |d Oxford : Oxford University Press, 1996 |g 21(2016), 4, Seite 487-493 |h Online-Ressource |w (DE-627)32063020X |w (DE-600)2023829-0 |w (DE-576)281196338 |x 1549-490X |7 nnas |a Novel treatments for rare cancers the U.S. orphan drug act is delivering : a cross-sectional analysis |
| 773 | 1 | 8 | |g volume:21 |g year:2016 |g number:4 |g pages:487-493 |g extent:7 |a Novel treatments for rare cancers the U.S. orphan drug act is delivering : a cross-sectional analysis |
| 856 | 4 | 0 | |u https://doi.org/10.1634/theoncologist.2015-0397 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828121/ |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190508 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 136385338 |a Ries, Markus |m 136385338:Ries, Markus |d 910000 |d 910500 |e 910000PR136385338 |e 910500PR136385338 |k 0/910000/ |k 1/910000/910500/ |p 4 |y j | ||
| 998 | |g 115652868 |a Hoffmann, Georg F. |m 115652868:Hoffmann, Georg F. |d 910000 |d 910500 |e 910000PH115652868 |e 910500PH115652868 |k 0/910000/ |k 1/910000/910500/ |p 3 | ||
| 998 | |g 1094705209 |a Lampert, Anette |m 1094705209:Lampert, Anette |d 910000 |d 910100 |e 910000PL1094705209 |e 910100PL1094705209 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 123997747 |a Stockklausner, Clemens |m 123997747:Stockklausner, Clemens |p 1 |x j | ||
| 999 | |a KXP-PPN1664981462 |e 3472179279 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"2016 Mar 28"}],"id":{"doi":["10.1634/theoncologist.2015-0397"],"eki":["1664981462"]},"recId":"1664981462","name":{"displayForm":["Clemens Stockklausner, Anette Lampert, Georg F. Hoffmann, Markus Ries"]},"title":[{"title_sort":"Novel treatments for rare cancers","subtitle":"the U.S. orphan drug act is delivering : a cross-sectional analysis","title":"Novel treatments for rare cancers"}],"person":[{"family":"Stockklausner","given":"Clemens","role":"aut","display":"Stockklausner, Clemens"},{"display":"Lampert, Anette","family":"Lampert","given":"Anette","role":"aut"},{"role":"aut","given":"Georg F.","family":"Hoffmann","display":"Hoffmann, Georg F."},{"display":"Ries, Markus","family":"Ries","given":"Markus","role":"aut"}],"physDesc":[{"extent":"7 S."}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"title":[{"subtitle":"the international peer-reviewed journal for the practicing oncologist, hematologist","title":"The oncologist","title_sort":"oncologist"}],"note":["Gesehen am 19.04.2022"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"pubHistory":["1.1996 -"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1996-","publisher":"Oxford University Press ; AlphaMed Press ; Wiley","dateIssuedKey":"1996","publisherPlace":"Oxford ; Miamisburg, Ohio ; Hoboken, NJ"}],"id":{"issn":["1549-490X"],"zdb":["2023829-0"],"eki":["32063020X"],"doi":["10.1002/(ISSN)1549-490X"]},"part":{"year":"2016","issue":"4","text":"21(2016), 4, Seite 487-493","extent":"7","volume":"21","pages":"487-493"},"recId":"32063020X","disp":"Novel treatments for rare cancers the U.S. orphan drug act is delivering : a cross-sectional analysisThe oncologist"}],"note":["Gesehen am 08.05.2019"]} | ||
| SRT | |a STOCKKLAUSNOVELTREAT2016 | ||